New contract awarded by u.s. department of defense for the procurement of up to approximately $7.5 million of oral tpoxx®

New york, may 12, 2022 (globe newswire) -- siga technologies, inc. (siga) (nasdaq: siga), a commercial-stage pharmaceutical company focused on the health security market, today announced that the u.s. department of defense (dod) awarded a contract to siga for the procurement of up to approximately $7.5 million of oral tpoxx, of which approximately $3.6 million of oral tpoxx is targeted for delivery in 2022 and the remainder is subject to an option at the sole discretion of the dod.
SIGA Ratings Summary
SIGA Quant Ranking